Dr. S. N. Vinaya Babu, founder and Managing Director of the company conceptualized the core business, growth strategies and attracted the right talent to build the organization. A successful serial entrepreneur Dr. S. N. Vinaya Babu has received various National awards.
He has been instrumental in terms of both strategic leadership and operational management in underpinning Bioneeds’ growth and evolution over past several years.
He completed his Veterinary graduation in the year 1998 and has over 17 years of experience in various segments of preclinical development. He has also published several research papers in national and international journals.
Dr. Nitin M. Shetty, is Head of Technical Operations at Bioneeds India Private Limited, Bangalore. A senior member of Preclinical services vertical from 2016, he played a pivotal role in setting up Multi-vertical Preclinical Service operations including infrastructure and business plans. In addition to his role as Head of Preclinical, he also led the preclinical and clinical development of molecules, Generics, Biotech products, Medical devices, Agro-chemicals and Chemical intermediates.
Dr Nitin M. Shetty, obtained his PhD from the Biological Sciences – Safety Assessment program, R. Ruia College, Mumbai at the University of Mumbai at Mumbai under the guidance of Dr. Rohini Sivabalan in whose laboratory he studied aspects of safety assessments in new drugs, generics and formulations and their role in pharmacokinetics and disposition.
Dr Nitin M Shetty, has over 30 years of pharma industry experience in drug discovery and development, in both R&D and CRO settings, in India. His in-depth understanding on national and global regulatory specifications for various product matrix add-values to precise strategizing and designing of projects. He started his drug discovery career at Ranbaxy Laboratory Limited, New Delhi in the year 1993 and later Joined Wockhardt Limited, Aurangabad, Maharashtra in 1998 and served as Associate Director – Safety Assessment Division, in the New Drug Discovery Research Division where he spent several years before joining a CRO to set up and head the Preclinical department at Vimta Labs Limited Research Laboratories, Hyderabad in 2009. Prior to joining Bioneeds, he was Vice President, Preclinical Services at Vimta Labs Limited where he supported the development of NCEs, biologics, generic drugs including medical devices.
Dr. Raghunath Reddy heads all technical operation at Bioneeds. He played a pivotal role in setting up Pre-clinical operations and has been with the Company for about 10 years. He has in depth knowledge and understanding of Global Regulatory requirements and has standardized many new toxicity studies to meet the regulatory requirements.
He was an active member of several Toxicology associations and scientific societies like STOX and AOT. He is also a member of Academy of Sciences for Animal Welfare.
Dr. Raghunath Reddy obtained his PhD from the Kuvempu University and has several acclaimed National & International publications. Prior to joining Bioneeds he has held technical leadership positions with Ranbaxy and Advinus Therapeutics.
Mr. Venu Madhava has extensive experience in various aspects of Finance, Accounting, Tax and Compliance matters over his working of 22 years with various Corporates. He has handled functions ranging from Exports, Corporate Treasury, Accounting, Audit, Investment Banking and Business Advisory. He has also handled Risk Management (Treasury, Forex), Credit Rating Exercise and Investor Relations.
He is a Fellow member of Institute of Chartered Accountants of India and Graduate member of ICWAI; has completed his graduation from Bangalore University. Prior to joining Bioneeds he has been associated with RSM & Co. (Presently part of PwC), ITC Limited, Britannia Industries, Praxair India and Makven Capital.
Ms. Sapna comes with a rich wide spectrum experience of over 20 years driving business development, strategy & marketing in the Drug Discovery and Development contract services space and Product Management.
With an excellent Business Development stint with Dr Reddy’s group – Aurigene Discovery Technologies, CPS and Molecular Connections, Jubilant Biosys and TATA group Advinus Therapeutics she has initiated and lead several collaborations& strategic relationships in global markets including large pharma. As Group Product Manager for Natural Remedies she has successfully launched several products which are Brand leaders in their segments. MsSapna holds to her credit General Management from IIM Bangalore, Diploma in Computer Programming, Degrees in Science and Education.
Dr. Susobhan Das is the CSO and Head of Biopharma Division at Bioneeds. He has over 20 years of experience in advanced biotechnology research (Protein-protein interaction and signal transduction in cancer) and Biopharmaceuticals development (Biologics drugs) and spearheaded several early stage Biosimilar product development starting from cell line creation complete with non-clinical studies using a CQA based approach at Intas Pharmaceuticals.
He has also led product development programs using novel therapeutic approaches such as gene / cell therapy for rare genetic disorders. Prior to joining Bioneeds, he was associated as a member of USP Biologics and Biotechnology Expert Panel, worked as a Director at USP-India. He has also served as a member of Expert committee on Biologicals and rDNA Products: IPC; Govt. of India. He has several research papers published in national and international peer-reviewed journals to his credit.
Dr. Susobhan Das holds M.Tech & PhD in Biotechnology from IIT, Kharagpur, a Postdoctoral from Nebraska Medical Centre, Omaha, Nebraska and postdoctoral and faculty positions from University of North Texas Health Science Centre, TX, USA.
Dr. Vadiraj. S. Gopinath, COO - Chemistry operations. He brings more than 23 years of knowledge and understanding of drug discovery, development, process chemistry and technology transfer for commercialization.
He obtained his PhD from the Mysore University and has several acclaimed National & International publications and patents. He did Post-doctoral work on drug discovery of cystic fibrosis correctors at University of California, San Francisco, USA. Prior to joining Bioneeds he has held technical leadership positions with GlaxoSmithKline, and Aurigene discovery labs (Dr Reddys Labs), Advinus Therapeutics Ltd (A TATA enterprise) and Rallis India Limited, A TATA Enterprise.
He was part of many global discovery and development programs. For discovery of novel lead compounds to develop treatment for Visceral Leishmaniasis, a Neglected diseases program, Won the prestigious JRD TATA global innovation award. This project was funded by Melinda Gates Foundation.